-
Je něco špatně v tomto záznamu ?
Communicating computational workflows in a regulatory environment
JG. Keeney, N. Gulzar, JB. Baker, O. Klempir, GD. Hannigan, DA. Bitton, JM. Maritz, CHS. King, JA. Patel, P. Duncan, R. Mazumder
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Odkazy
PubMed
38219969
DOI
10.1016/j.drudis.2024.103884
Knihovny.cz E-zdroje
- MeSH
- průběh práce MeSH
- vakcíny * MeSH
- výpočetní biologie * MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Publikační typ
- časopisecké články MeSH
The volume of nucleic acid sequence data has exploded recently, amplifying the challenge of transforming data into meaningful information. Processing data can require an increasingly complex ecosystem of customized tools, which increases difficulty in communicating analyses in an understandable way yet is of sufficient detail to enable informed decisions or repeats. This can be of particular interest to institutions and companies communicating computations in a regulatory environment. BioCompute Objects (BCOs; an instance of pipeline documentation that conforms to the IEEE 2791-2020 standard) were developed as a standardized mechanism for analysis reporting. A suite of BCOs is presented, representing interconnected elements of a computation modeled after those that might be found in a regulatory submission but are shared publicly - in this case a pipeline designed to identify viral contaminants in biological manufacturing, such as for vaccines.
Exploratory Science Center Merck and Co Cambridge MA USA
Merck and Co Kenilworth NJ USA
R and D Informatics Solutions MSD Czech Republic Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006917
- 003
- CZ-PrNML
- 005
- 20240423155556.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.drudis.2024.103884 $2 doi
- 035 __
- $a (PubMed)38219969
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Keeney, Jonathon G $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA. Electronic address: keeneyjg@gwu.edu
- 245 10
- $a Communicating computational workflows in a regulatory environment / $c JG. Keeney, N. Gulzar, JB. Baker, O. Klempir, GD. Hannigan, DA. Bitton, JM. Maritz, CHS. King, JA. Patel, P. Duncan, R. Mazumder
- 520 9_
- $a The volume of nucleic acid sequence data has exploded recently, amplifying the challenge of transforming data into meaningful information. Processing data can require an increasingly complex ecosystem of customized tools, which increases difficulty in communicating analyses in an understandable way yet is of sufficient detail to enable informed decisions or repeats. This can be of particular interest to institutions and companies communicating computations in a regulatory environment. BioCompute Objects (BCOs; an instance of pipeline documentation that conforms to the IEEE 2791-2020 standard) were developed as a standardized mechanism for analysis reporting. A suite of BCOs is presented, representing interconnected elements of a computation modeled after those that might be found in a regulatory submission but are shared publicly - in this case a pipeline designed to identify viral contaminants in biological manufacturing, such as for vaccines.
- 650 12
- $a výpočetní biologie $7 D019295
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 12
- $a vakcíny $7 D014612
- 650 _2
- $a průběh práce $7 D057188
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gulzar, Naila $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
- 700 1_
- $a Baker, Jack B $u Merck & Co., Kenilworth, NJ, USA
- 700 1_
- $a Klempir, Ondrej $u R&D Informatics Solutions, MSD Czech Republic, Prague, Czech Republic
- 700 1_
- $a Hannigan, Geoffrey D $u Exploratory Science Center, Merck & Co., Cambridge, MA, USA
- 700 1_
- $a Bitton, Danny A $u R&D Informatics Solutions, MSD Czech Republic, Prague, Czech Republic
- 700 1_
- $a Maritz, Julia M $u Exploratory Science Center, Merck & Co., Cambridge, MA, USA
- 700 1_
- $a King, Charles H S $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
- 700 1_
- $a Patel, Janisha A $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
- 700 1_
- $a Duncan, Paul $u Merck & Co., Kenilworth, NJ, USA
- 700 1_
- $a Mazumder, Raja $u Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA
- 773 0_
- $w MED00173737 $t Drug discovery today $x 1878-5832 $g Roč. 29, č. 3 (2024), s. 103884
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38219969 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155553 $b ABA008
- 999 __
- $a ok $b bmc $g 2081098 $s 1216684
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 3 $d 103884 $e 20240112 $i 1878-5832 $m Drug discovery today $n Drug Discov Today Dis Mech $x MED00173737
- LZP __
- $a Pubmed-20240412